Viewing Study NCT06027892


Ignite Creation Date: 2025-12-24 @ 3:58 PM
Ignite Modification Date: 2025-12-29 @ 9:48 AM
Study NCT ID: NCT06027892
Status: RECRUITING
Last Update Posted: 2024-11-15
First Post: 2023-08-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate Cancer
Sponsor: Rabin Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module